GCTK logo

GLUCOTRACK INC

GCTKNASDAQ
🏆 #5385 by market capUS Equity
$669.73▲ $24.38 (+3.64%)
Simulated price
🔔
Track GCTK
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 3.6%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$1M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
19.2x
Expensive
Otter Score
40
Weak
No chart data available for GCTK.

Trading Snapshot

Day Range
$662.28 – $681.64
52-Week Range
$1.77 – $136.29
Volume
$3.19B
Avg Volume
$2.28B
Shares Outstanding
7.7M
Next Earnings
Nov 4, 2026

Fundamentals Snapshot

Annual Revenue
$75,000
Last Q Revenue
$19,581
P/E Ratio
—
P/S Ratio
19.2x
EPS (TTM)
$-115.36
Dividend Yield
—
Dilution (1yr)
+172.4%

Why Investors Own GCTK

  • ✓High-growth profile — revenue up +0.1% YoY with expanding US Equity exposure.
  • ✓Healthy economics — 30% gross margin and 12% free-cash-flow margin.
  • ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

GCTK logo

GLUCOTRACK INC

GCTK
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0▲ +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$16M▲ +10.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$15M▲ +21.8% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
60K▲ +172.4% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$7M▲ +$2M YoY
StockOtter · stockotter.space

About GLUCOTRACK INC

Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)
💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
40/100

Analyst Price Target

ⓘ
Average Target
$738.88
▲ +10.3% Upside
High Target$918.93
Low Target$650.48
Based on 32 analysts

Latest News & Updates

🚀
Bloomberg·2h ago

GLUCOTRACK INC tops quarterly estimates as demand accelerates

Revenue grew double digits with management guiding above consensus; margins continued to expand.

🛰️
Barron’s·5h ago

Analysts lift GCTK price targets on improving margins

Several firms raised targets, citing stronger free cash flow and a healthier backlog.

🌌
Bloomberg·1d ago

GLUCOTRACK INC announces new agreement to expand its footprint

The move broadens the company’s reach and could add incremental revenue over the next year.